NASDAQ:INVO INVO Bioscience (INVO) Stock Price, News & Analysis → The best trading strategy for markets right now (From DTI) (Ad) Free INVO Stock Alerts $0.96 -0.11 (-10.28%) (As of 04:00 PM ET) Add Compare Share Share Today's Range$0.93▼$1.0750-Day Range$0.74▼$1.8252-Week Range$0.50▼$7.20Volume144,073 shsAverage Volume2.12 million shsMarket Capitalization$3.66 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get INVO Bioscience alerts: Email Address Ad Crypto 101 Media$16T Crypto Plot From Elon MuskReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. About INVO Bioscience Stock (NASDAQ:INVO)INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.Read More INVO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INVO Stock News HeadlinesJune 16 at 1:34 AM | americanbankingnews.comWest Pharmaceutical Services (NYSE:WST) and INVO Bioscience (NASDAQ:INVO) Critical ComparisonMay 15, 2024 | msn.comINVO Stock Earnings: INVO Bioscience Reported Results for Q1 2024June 18, 2024 | DTI (Ad)The best trading strategy for markets right nowAre we in a bull market or about to head into a recession? Will there be war or will there be peace? Will interest rates rise or go lower? Who knows! And I don’t really care. Because I’ve discovered a trading strategy that doesn’t depend on what the rest of the world is doing. But with just one trade, I can target up to $2k or more in trade income every single week, starting with as little as $500. May 15, 2024 | globenewswire.comINVO Reports Record First Quarter 2024 Financial ResultsApril 24, 2024 | finance.yahoo.comINVO Bioscience, Inc. (INVO) Stock Price, News, Quote & History - Yahoo FinanceApril 17, 2024 | msn.comMicro Cap Massively Bid Up Before Opening BellApril 17, 2024 | benzinga.comWhy Invo BioScience Stock Is Soaring TodayApril 17, 2024 | msn.comWhy Is Invo Bioscience (INVO) Stock Up 85% Today?June 18, 2024 | DTI (Ad)The best trading strategy for markets right nowAre we in a bull market or about to head into a recession? Will there be war or will there be peace? Will interest rates rise or go lower? Who knows! And I don’t really care. Because I’ve discovered a trading strategy that doesn’t depend on what the rest of the world is doing. But with just one trade, I can target up to $2k or more in trade income every single week, starting with as little as $500. April 17, 2024 | investorplace.comWhy Is Invo Bioscience (INVO) Stock Up 85% Today?April 17, 2024 | benzinga.comWhy INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving PremarketApril 17, 2024 | finance.yahoo.comAadi Bioscience, Inc. (AADI) Latest Stock News & Headlines - Yahoo FinanceApril 16, 2024 | msn.comINVO Stock Earnings: INVO Bioscience Reported Results for Q4 2023April 16, 2024 | finance.yahoo.comINVO Reports Fourth Quarter and Full Year 2023 Financial ResultsApril 4, 2024 | seekingalpha.comASMB Assembly Biosciences, Inc.February 22, 2024 | benzinga.comINVO Bioscience Stock (NASDAQ:INVO), Short Interest ReportFebruary 4, 2024 | morningstar.comINVO Bioscience Inc INVOJanuary 23, 2024 | marketwatch.comINVO BioScience Shares Up 5% as NAYA Agrees to Buy Florida BiotechnologiesJanuary 23, 2024 | finance.yahoo.comNAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)January 23, 2024 | finance.yahoo.comNAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)January 17, 2024 | finance.yahoo.comINVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board DirectorsDecember 23, 2023 | finance.yahoo.comINVO Bioscience, Inc. (INVO) Stock Historical Prices & Data - Yahoo FinanceDecember 11, 2023 | finance.yahoo.comNAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood JournalDecember 6, 2023 | msn.comNAYA, ONK team up to evaluate potential cancer therapy combinationsDecember 6, 2023 | finance.yahoo.comNAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK™ Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell TherapiesNovember 28, 2023 | finance.yahoo.comINVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity RequirementNovember 14, 2023 | benzinga.comWhy INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving PremarketSee More Headlines Receive INVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for INVO Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2024Today6/18/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:INVO CUSIPN/A CIK1417926 Webwww.invobioscience.com Phone(978) 878-9505FaxN/AEmployees25Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,030,000.00 Net Margins-459.42% Pretax Margin-265.05% Return on EquityN/A Return on Assets-88.87% Debt Debt-to-Equity Ratio2.94 Current Ratio0.19 Quick Ratio0.16 Sales & Book Value Annual Sales$4.25 million Price / Sales0.96 Cash FlowN/A Price / Cash FlowN/A Book Value($2.06) per share Price / Book-0.52Miscellaneous Outstanding Shares3,809,000Free Float3,676,000Market Cap$4.08 million OptionableNo Data Beta1.48 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Steven M. Shum (Age 53)CEO & Director Comp: $260kMr. Andrea Goren (Age 57)Chief Financial Officer Comp: $215kMr. Michael Jos. Campbell (Age 66)COO & VP of Business Development Comp: $220kMr. Bojan Mitrovic Ph.D.Director of Sales USMr. Robert Joseph Bowdring Jr. (Age 66)Treasurer & Secretary Ms. Terah KrigsvoldControllerMore ExecutivesKey CompetitorsPAVmedNASDAQ:PAVMPetVivoNASDAQ:PETVSTRATA Skin SciencesNASDAQ:SSKNBiotricityNASDAQ:BTCYVivos TherapeuticsNASDAQ:VVOSView All Competitors INVO Stock Analysis - Frequently Asked Questions How have INVO shares performed in 2024? INVO Bioscience's stock was trading at $1.35 at the start of the year. Since then, INVO shares have decreased by 29.3% and is now trading at $0.9544. View the best growth stocks for 2024 here. Are investors shorting INVO Bioscience? INVO Bioscience saw a drop in short interest during the month of May. As of May 31st, there was short interest totaling 30,900 shares, a drop of 62.0% from the May 15th total of 81,300 shares. Based on an average daily volume of 3,770,000 shares, the short-interest ratio is presently 0.0 days. Approximately 0.8% of the shares of the company are short sold. View INVO Bioscience's Short Interest. When is INVO Bioscience's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024. View our INVO earnings forecast. How were INVO Bioscience's earnings last quarter? INVO Bioscience, Inc. (NASDAQ:INVO) issued its quarterly earnings data on Wednesday, May, 15th. The company reported ($0.42) earnings per share (EPS) for the quarter. The business had revenue of $1.58 million for the quarter. When did INVO Bioscience's stock split? INVO Bioscience's stock reverse split before market open on Thursday, July 27th 2023. The 1-20 reverse split was announced on Thursday, July 27th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. How do I buy shares of INVO Bioscience? Shares of INVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:INVO) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | Sponsoredwhy 99.94% won’t make you moneyI believe there's only 5-7 stocks that you should trade in 2024. But here's the catch…because there's alway...Prosper Trading Academy | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.